Akums Drugs and Pharmaceuticals Limited (NSEI: AKUMS)
Health Care · Life Sciences Tools & Services · IN
Rs726.60
+4.18% today · +53.1% 1Y
Akums Drugs and Pharmaceuticals Limited (NSEI: AKUMS) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $1.16B and employs 7,337 people.
Over the last twelve months the share price has gained 53.1%, trading between 409.30 and 714.70.
Tweenvest scores Akums Drugs and Pharmaceuticals Limited across four factors: quality 70/100, value 37/100, growth 44/100, dividend 39/100. Its strongest factor is quality.
AKUMS price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.16B
- Revenue (TTM)
- $476.35M
- P/E
- 38.15
- EPS
- 19.05
- Dividend yield
- 0.14%
- Beta (5Y)
- 0.55
- 52-week high
- Rs714.70
- 52-week low
- Rs409.30
- Avg volume (3M)
- —
- Shares outstanding
- 153.10M
- Employees
- 7,337
- Next earnings
- —
About Akums Drugs and Pharmaceuticals Limited
Akums Drugs & Pharmaceuticals Ltd. is an Indian-based company, established in 2004 and headquartered in Delhi, that operates globally as a manufacturer and supplier of both finished pharmaceutical products and active pharmaceutical ingredients (APIs). Its diverse product range encompasses conventional drugs, traditional Ayurvedic and herbal remedies, personal care items including toiletries, nutraceuticals, food and dietary supplements, dermatological and cosmetic products, and healthcare and hospital supplies, along with over-the-counter (OTC) solutions. The company also deals in excipients and various chemical compounds. Akums develops and markets its own branded formulations across a variety of dosage forms, such as tablets, capsules, injectables, ophthalmic preparations, and soft gelatin capsules. These products address a broad spectrum of therapeutic areas, including gynaecology, cardiology, orthopaedics, pediatrics, dermatology, anti-infectives, pain management, and gastroenterology. Furthermore, Akums Drugs & Pharmaceuticals provides services as a pharmaceutical contract development and manufacturing organization (CDMO).
- ISIN
- INE09XN01023
- Founded
- 2004
- Listed since
- Aug 6, 2024
- Exchange
- National Stock Exchange of India
- Currency
- INR
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Thermo Fisher Scientific Inc.NYSE: TMO | $232.26B | $628.15 | -0.09% |
| Danaher CorporationNYSE: DHR | $151.82B | $215.97 | +0.40% |
| WuXi AppTec Co., Ltd.SHSE: 603259 | $71.35B | CN¥161.00 | +3.31% |
| Samsung Biologics Co.,Ltd.KOSE: A207940 | $51.75B | ₩1,551,000.00 | +0.19% |
| Lonza Group AGSWX: LONN | $51.65B | CHF593.80 | +1.02% |
| Agilent Technologies, Inc.NYSE: A | $43.71B | $154.77 | +0.87% |
| IQVIA Holdings Inc.NYSE: IQV | $42.70B | $259.42 | -0.32% |
| Waters CorporationNYSE: WAT | $40.72B | $414.44 | +0.90% |
Figures last refreshed Aug 18, 2026.